These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 6298467)
21. Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2. Martin DR; Yuryev A; Kalli KR; Fearon DT; Ahearn JM J Exp Med; 1991 Dec; 174(6):1299-311. PubMed ID: 1660522 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats. Moore MD; Cannon MJ; Sewall A; Finlayson M; Okimoto M; Nemerow GR J Virol; 1991 Jul; 65(7):3559-65. PubMed ID: 1645784 [TBL] [Abstract][Full Text] [Related]
24. Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells. Haddad RS; Hutt-Fletcher LM J Virol; 1989 Dec; 63(12):4998-5005. PubMed ID: 2555536 [TBL] [Abstract][Full Text] [Related]
25. Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cells. Wells A; Koide N; Klein G J Virol; 1982 Jan; 41(1):286-97. PubMed ID: 6283120 [TBL] [Abstract][Full Text] [Related]
26. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588 [TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus (EBV) receptor implantation onto human B lymphocytes changes immunoglobulin secretion patterns induced by EBV infection. Tsukuda K; Volsky DJ; Shapiro IM; Klein G Eur J Immunol; 1982 Jan; 12(1):87-90. PubMed ID: 6277643 [TBL] [Abstract][Full Text] [Related]
28. Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction. Masucci MG; Szigeti R; Ernberg I; Hu CP; Torsteinsdottir S; Frade R; Klein E Eur J Immunol; 1987 Jun; 17(6):815-20. PubMed ID: 3036539 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus binding to virus-carrying cell lines is enhanced in the presence of C3 and C3d. Wells A; Koide N; Eggertsen G; Lundwall A; Godal T; Steen HB; Klein G J Gen Virol; 1984 Mar; 65 ( Pt 3)():507-13. PubMed ID: 6321638 [TBL] [Abstract][Full Text] [Related]
30. Membrane-bound antiviral antibodies as receptors for Sendai virions in receptor-depleted erythrocytes. Nussbaum O; Zakai N; Loyter A Virology; 1984 Oct; 138(2):185-97. PubMed ID: 6093364 [TBL] [Abstract][Full Text] [Related]
31. Model for studying virus attachment: identification and quantitation of Epstein-Barr virus-binding cells by using biotinylated virus in flow cytometry. Inghirami G; Nakamura M; Balow JE; Notkins AL; Casali P J Virol; 1988 Jul; 62(7):2453-63. PubMed ID: 2836625 [TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus (EBV)-lymphoid cell interactions. I. Quantification of EBV particles required for the membrane immunofluorescence assay and the comparative expression of EBV receptors on different human B, T and null cell lines. Patel P; Menezes J J Gen Virol; 1981 Mar; 53(Pt 1):1-11. PubMed ID: 6268736 [TBL] [Abstract][Full Text] [Related]
33. Restrictions upon Epstein-Barr virus infection of the leukemic cell are demonstrated in patients with hairy cell leukemia. Sairenji T; Reisert PS; Spiro RC; Mulder C; Humphreys RE Hematol Oncol; 1983; 1(3):251-62. PubMed ID: 6329936 [TBL] [Abstract][Full Text] [Related]
34. Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3. Ah-Tye C; Schwartz S; Huberman K; Carlin E; Moscona A Microb Pathog; 1999 Nov; 27(5):329-36. PubMed ID: 10545258 [TBL] [Abstract][Full Text] [Related]
35. Functional association of class II antigens with cell surface binding of Epstein-Barr virus. Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696 [TBL] [Abstract][Full Text] [Related]
36. Adsorption of LLCMK2 cell-grown Sendai virus onto human red blood cells and its release from the virus adsorbed cells. Komatsu H; Tozawa H Microbiol Immunol; 1988; 32(12):1201-10. PubMed ID: 2853288 [TBL] [Abstract][Full Text] [Related]
37. Infection of human epithelial cells by Epstein-Barr virus (EBV). II. Biochemical characterization of EBV-determined proteins synthesized in epithelial cells. Sinangil F; Volsky B; Volsky DJ Virus Res; 1985 Oct; 3(3):207-12. PubMed ID: 3000099 [TBL] [Abstract][Full Text] [Related]
38. Affinity targeting of Sendai virions to desialized human erythrocytes using hybrid antibody molecules. Chejanovsky N; Fridlender B; Loyter A Biochim Biophys Acta; 1985 Jan; 812(2):353-60. PubMed ID: 2981547 [TBL] [Abstract][Full Text] [Related]
39. Events related to Epstein-Barr virus binding and superinfection of Raji cells. Barile G; Di Certo MG; Cirone M; Frati L; Pontieri GM; Faggioni A; Di Renzo L Intervirology; 1994; 37(5):245-51. PubMed ID: 7698879 [TBL] [Abstract][Full Text] [Related]
40. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes. Nemerow GR; McNaughton ME; Cooper NR J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]